PMA
P860046: THERAPEUTIC ULTRASOUND FOR TREATMENT OF GLAUCOMA
FDA PMA · Ultrasound, cyclodestructive · Sonocare, Inc.
Key facts
| PMA number | P860046 |
|---|---|
| Trade name | THERAPEUTIC ULTRASOUND FOR TREATMENT OF GLAUCOMA |
| Generic name | Ultrasound, cyclodestructive |
| Applicant | Sonocare, Inc. |
| Product code | LZR |
| Approval date | Jun 30, 1988 |
| Docket number | 88M-0266 |
| Notice date | Aug 10, 1988 |
| FEI number | 3010591863 |
At a glance
- None Supplements
- Jun 30, 1988 Latest supplement decision
- No Withdrawn
- No Summary of safety and effectiveness on file
- None UDI device identifiers (GUDID)
- None MAUDE adverse event reports
- None Recall events
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA approvals
Premarket approval (PMA) is the FDA's most stringent review pathway, required for most Class III devices that support or sustain life or present a potentially unreasonable risk.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: